뉴로핏

380550KOSDAQ소프트웨어 개발 및 공급업

50.9 / 100

Reference Date: 2026-06-10

Financial Score19.0 / 40

News Sentiment19.9 / 25

Momentum2.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but PBR raises overvaluation concerns. Plunged 34.0% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Neurophet is a company specializing in medical imaging solutions for neurodegenerative diseases, particularly Alzheimer's, offering products like Neurophet AQUA AD, which assesses Amyloid-Related Imaging Abnormalities (ARIA) severity. The company holds international certifications such as CE, FDA 510K, and GMP, and provides Clinical Research Organization (CRO) services to support medical device development.

Number of Employees

139people

Average Salary

58.1M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 13.624.0Point

PBR

7.86Industry Average 1.020.0Point

7.7x industry avg (risky)

ROE

—Industry Average 1.103.5Point

Debt Ratio

2.55Industry Average 7.936.5Point

Half of industry avg (excellent)

Trend 5.0 / 10 points

Revenue Growth Rate

1.5 / 3

Operating Profit Growth Rate

1.5 / 3

ROE Trend

2.0 / 4

Detailed News Sentiment

13 totalPositive 11Neutral 2Negative 0Average Sentiment Score 79.6

Positive
뉴로핏, 서울대병원 등 4개 상급종합병원에 치매 치료제 모니터링 소.....
뉴로핏의 치매 치료제 모니터링 소프트웨어가 서울대병원 등 주요 병원들과 협력하여 임상 데이터 수집 및 분석 능력을 강화함으로써 시장 경쟁력이 향상되었다.
Positive
뉴로핏, 국내 상급종합병원 4곳에 '의료AI' 공급
뉴로핏의 의료AI 소프트웨어가 국내 주요 상급종합병원에 공급되어 치매 치료제 모니터링에 활용되며, 향후 더 넓은 의료기관으로의 확장이 기대된다.
Positive
뉴로핏, 국제 정보보안 인증 'ISO 27001 및 27701' 획득
뉴로핏의 국제 정보보안 인증 획득으로 보안성 강화 및 신뢰성 향상 기대.

Detailed Momentum

52-week position1.0Point

Near 52w low (8%, downtrend)

Current 12,530Won52-week high 36,70052-week low 10,300

1-month return0.0Point

1m -34.05% (strong drop)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

4 totalPositive 0Neutral 4Negative 0

Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-06-01
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-06-01
Neutral주식등의대량보유상황보고서(일반)2026-06-01
Neutral분기보고서 (2026.03)2026-05-15